JP2008110970A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008110970A5 JP2008110970A5 JP2007260968A JP2007260968A JP2008110970A5 JP 2008110970 A5 JP2008110970 A5 JP 2008110970A5 JP 2007260968 A JP2007260968 A JP 2007260968A JP 2007260968 A JP2007260968 A JP 2007260968A JP 2008110970 A5 JP2008110970 A5 JP 2008110970A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- azelastine
- anticholinergic agent
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 17
- 239000000812 cholinergic antagonist Substances 0.000 claims 6
- MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 claims 5
- 229960004574 azelastine Drugs 0.000 claims 5
- 241001106067 Atropa Species 0.000 claims 3
- 206010006451 Bronchitis Diseases 0.000 claims 2
- 206010011224 Cough Diseases 0.000 claims 2
- 210000002175 Goblet Cells Anatomy 0.000 claims 2
- 206010020718 Hyperplasia Diseases 0.000 claims 2
- 206010036790 Productive cough Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229930006677 A03BA01 - Atropine Natural products 0.000 claims 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 claims 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N Atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 claims 1
- 229960000396 Atropine Drugs 0.000 claims 1
- 229960004335 Azelastine hydrochloride Drugs 0.000 claims 1
- 206010006458 Bronchitis chronic Diseases 0.000 claims 1
- 208000007451 Chronic Bronchitis Diseases 0.000 claims 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 claims 1
- JTPUMZTWMWIVPA-UHFFFAOYSA-O Isopropamide Chemical compound C=1C=CC=CC=1C(C(N)=O)(CC[N+](C)(C(C)C)C(C)C)C1=CC=CC=C1 JTPUMZTWMWIVPA-UHFFFAOYSA-O 0.000 claims 1
- VVWYOYDLCMFIEM-UHFFFAOYSA-N Propantheline Chemical compound C1=CC=C2C(C(=O)OCC[N+](C)(C(C)C)C(C)C)C3=CC=CC=C3OC2=C1 VVWYOYDLCMFIEM-UHFFFAOYSA-N 0.000 claims 1
- 206010057190 Respiratory tract infection Diseases 0.000 claims 1
- STECJAGHUSJQJN-FWXGHANASA-N Scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 claims 1
- 230000001154 acute Effects 0.000 claims 1
- 150000003797 alkaloid derivatives Chemical class 0.000 claims 1
- 229930013930 alkaloids Natural products 0.000 claims 1
- YEJAJYAHJQIWNU-UHFFFAOYSA-N azelastine hydrochloride Chemical group Cl.C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 YEJAJYAHJQIWNU-UHFFFAOYSA-N 0.000 claims 1
- 229940108858 belladonna total alkaloids Drugs 0.000 claims 1
- 230000001684 chronic Effects 0.000 claims 1
- 229940000425 combination drugs Drugs 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 229960001737 isopropamide Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229960000697 propantheline Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229960002646 scopolamine Drugs 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
Claims (14)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007260968A JP5208473B2 (en) | 2006-10-06 | 2007-10-04 | Pharmaceutical composition containing azelastine and anticholinergic agent |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006274657 | 2006-10-06 | ||
| JP2006274657 | 2006-10-06 | ||
| JP2007260968A JP5208473B2 (en) | 2006-10-06 | 2007-10-04 | Pharmaceutical composition containing azelastine and anticholinergic agent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008110970A JP2008110970A (en) | 2008-05-15 |
| JP2008110970A5 true JP2008110970A5 (en) | 2010-10-21 |
| JP5208473B2 JP5208473B2 (en) | 2013-06-12 |
Family
ID=39443697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007260968A Active JP5208473B2 (en) | 2006-10-06 | 2007-10-04 | Pharmaceutical composition containing azelastine and anticholinergic agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5208473B2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015023328A2 (en) | 2013-03-13 | 2017-07-18 | Flatley Discovery Lab | pyridazinone compounds and methods for treating cystic fibrosis |
| CN103919919A (en) * | 2014-04-24 | 2014-07-16 | 张艳霞 | Chinese herba preparation for treating cold, as well as preparation method thereof |
| CN104667084A (en) * | 2015-02-03 | 2015-06-03 | 林亚梅 | Traditional Chinese medicine for treating intestinal tuberculosis |
| CN104825972B (en) * | 2015-05-25 | 2018-07-27 | 辽宁阔安生物科技有限公司 | A kind of vinegar leaching Chinese herbal ultra-fine powder preparation of prevention farm animal and bird plague |
| CN105031328A (en) * | 2015-07-06 | 2015-11-11 | 陈彬 | Traditional Chinese medicine composition used for treating wind-heat superficies-attached cold, and preparation method thereof |
| CN104998103A (en) * | 2015-07-06 | 2015-10-28 | 陈彬 | Traditional Chinese medicine composition for treating common cold with syndrome of wind-cold fettering the exterior and preparation method thereof |
| CN104997821A (en) * | 2015-07-07 | 2015-10-28 | 扬子江药业集团北京海燕药业有限公司 | Use of Radix Peucedani extract in immune function improvement |
| CN105012766A (en) * | 2015-08-20 | 2015-11-04 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treating bronchiectasis in stable period |
| CN105012704A (en) * | 2015-08-20 | 2015-11-04 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treating liver-fire attacking lung type hemoptysis due to bronchiectasis |
| CN105012703A (en) * | 2015-08-20 | 2015-11-04 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treating qi-deficiency and blood-stasis type bronchiectasis associated with hemoptysis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4377564B2 (en) * | 2002-05-02 | 2009-12-02 | ロート製薬株式会社 | Composition for internal use |
| JP2004067690A (en) * | 2002-07-26 | 2004-03-04 | Takeda Chem Ind Ltd | Furoisoquinoline inducer and its application |
| CA2552458A1 (en) * | 2004-02-06 | 2005-08-18 | Meda Pharma Gmbh & Co. Kg | Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids |
-
2007
- 2007-10-04 JP JP2007260968A patent/JP5208473B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008110970A5 (en) | ||
| CN104870017B (en) | Pharmaceutical composition containing PDE4 inhibitor and PI3 or dual PI 3-gamma kinase inhibitor | |
| JP5208473B2 (en) | Pharmaceutical composition containing azelastine and anticholinergic agent | |
| JP2014506321A5 (en) | ||
| WO2008002245A3 (en) | Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) | |
| JP2007197423A5 (en) | ||
| MXPA03010731A (en) | Combination of an adenosine a2a. | |
| IL198314A (en) | Quinuclidine derivatives of (hetero) arylcycloheptanecarboxylic acid, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for therapy | |
| WO2008002244A8 (en) | Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) | |
| JP2009541443A5 (en) | ||
| NZ593695A (en) | Alkaloid aminoester derivatives and medicinal composition thereof | |
| JP2012512158A5 (en) | ||
| JP2009280621A5 (en) | ||
| JP2018090566A5 (en) | ||
| CA2671954A1 (en) | Methods for treating or preventing symptoms of hormonal variations | |
| JP2007515426A5 (en) | ||
| CY1110152T1 (en) | USING COMBINATION OF MORPHINE AND AT LEAST ONE PHYSICAL OPIOEIDOUS ANTAGONIST IN THE TREATMENT OF ADDICTION FROM NATURAL OPIOID AND PREVENTING ABUSE MH ORAL opiate EXARTIMENOUS IN NATURAL OPIOID | |
| JP5091474B2 (en) | Pharmaceutical composition containing fudosteine and anticholinergic agent | |
| US11779581B2 (en) | Opioid for use to reduce and/or treat drug addiction | |
| JP2011500650A5 (en) | ||
| JP2011513315A5 (en) | ||
| JP2012500248A (en) | Treatment of anxiety disorder | |
| Maqsood et al. | The role of revefenacin in chronic obstructive pulmonary disease | |
| US20110313153A1 (en) | 5-ht4 inhibitors for treating airway diseases, in particular asthma | |
| WO2013128088A8 (en) | Use of modafinil in the treatment of cocaine addicts |